SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Offer for Subscription – Over-Allotment Facility

25 Mar 2026 17:01

RNS Number : 1456Y
Puma VCT 13 PLC
25 March 2026
 

Puma VCT 13 plc

25 March 2026

Offer for Subscription - Exercise of Over-Allotment Facility

On 24 September 2025, Puma VCT 13 plc (the "Company") published a prospectus in relation to an offer for subscription for new Ordinary Shares of £0.0005 each in the Company to raise up to £50 million, with an over-allotment facility to raise up to a further £20 million (the "Offer").

Following strong demand for the Offer, the directors of the Company have resolved to exercise the over-allotment facility referred to in the prospectus and, accordingly, the maximum amount that the Company can raise under the Offer is increased to £70 million.

A copy of the prospectus relating to the Offer is available on https://www.pumainvestments.co.uk/products/venture-capital-trusts/puma-vct-13

For further information please contact:

Eliot Kaye

Company Secretary

Puma VCT 13 plc

020 7408 4050

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFERVEIEFIR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS